Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration in the Mediastinal Staging of Non-Small Cell Lung Cancer: A Meta-Analysis

Xifeng Dong,Xiaochun Qiu,Qian Liu,Jack Jia

DOI: https://doi.org/10.1016/j.athoracsur.2013.05.016

2013-01-01

Abstract:In this article, we assessed the pooled sensitivity and specificity of endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) in studies during the last 10 years that have solely used EBUS-TBNA as a minimally invasive technique, with or without computed tomography or positron-emission tomography screening. The meta-analysis included 1,066 patients from 9 studies who underwent EBUS-TBNA. The results show EBUS-TBNA is a potential technique for the investigation, diagnosis, and staging of non-small cell lung cancer among patients with suspected lung cancer. It has excellent sensitivity, specificity, accuracy, positive predictive value, and negative predictive value. EBUS-TBNA is well tolerated and does not lead to complications in patients. In this article, we assessed the pooled sensitivity and specificity of endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) in studies during the last 10 years that have solely used EBUS-TBNA as a minimally invasive technique, with or without computed tomography or positron-emission tomography screening. The meta-analysis included 1,066 patients from 9 studies who underwent EBUS-TBNA. The results show EBUS-TBNA is a potential technique for the investigation, diagnosis, and staging of non-small cell lung cancer among patients with suspected lung cancer. It has excellent sensitivity, specificity, accuracy, positive predictive value, and negative predictive value. EBUS-TBNA is well tolerated and does not lead to complications in patients. Accurate assessment of mediastinal lymph nodes in patients with lung cancer is crucial for staging and deciding treatment options for non-small cell lung cancer (NSCLC) [1Detterbeck F.C. Jantz M.A. Wallace M. Vansteenkiste J. Silvestri G.A. American College of Chest Physicians. Invasive mediastinal staging of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition).Chest. 2007; 132 (202-20S)Google Scholar, 2Silvestri G.A. Gould M.K. Margolis M.L. et al.Noninvasive staging of non-small cell lung cancer: ACCP evidenced-based clinical practice guidelines (2nd edition).Chest. 2007; 132: 178-201SAbstract Full Text Full Text PDF PubMed Scopus (554) Google Scholar]. This has triggered the need for a reliable technique for the staging of the mediastinum. Mediastinoscopy is considered the gold standard method for the diagnosis and staging of mediastinal masses and lymph nodes [1Detterbeck F.C. Jantz M.A. Wallace M. Vansteenkiste J. Silvestri G.A. American College of Chest Physicians. Invasive mediastinal staging of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition).Chest. 2007; 132 (202-20S)Google Scholar]. However, mediastinoscopy is an invasive technique that requires general anesthesia, cannot evaluate the hilar lymph nodes [3Ernst A. Gangadharan S.P. A good case for a declining role for mediastinoscopy just got better.Am J Respr Crit Care Med. 2008; 177: 471-472Crossref PubMed Scopus (15) Google Scholar], and cannot be easily used in restaging [4Khoo K.L. Mediastinal re-staging of non small-cell lung cancer.Thoracic Cancer. 2012; 3: 145-149Crossref PubMed Scopus (6) Google Scholar]. The invasive nature of mediastinoscopy has led to a considerable interest in the development of noninvasive or minimally invasive techniques. In recent years, minimally invasive ultrasound-guided techniques using needle biopsy to obtain tissue samples from mediastinal lymph nodes have gained popularity. These techniques include transbronchial endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) [5Jacobson B.C. Hirota W.K. Goldstein J.L. et al.The role of EUS for evaluation of mediastinal adenopathy.Gastrointest Endosc. 2003; 58: 819-821Abstract Full Text Full Text PDF PubMed Scopus (23) Google Scholar] and, most recently, endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA). EUS-FNA shows mediastinal lymph nodes under real-time ultrasound control from the esophagus. EUS-FNA has shown good results but does not allow the inspection of airways [6Fritscher-Ravens A. Davidson B.L. et al.Endoscopic ultrasound, positron emission tomography, and computerized tomography for lung cancer.Am J Respr Crit Car Med. 2003; 168: 1293-1297Crossref PubMed Scopus (76) Google Scholar]. EBUS-TBNA was first described in 1992 [7Hurter T. Hanrath P. Endobronchial sonography: feasibility and preliminary results.Thorax. 1992; 47: 565-567Crossref PubMed Scopus (205) Google Scholar] and has become quite popular among bronchoscopists around the world. EBUS-TBNA is a quicker technique that can be performed as a day case out of the operating theater and is less invasive [8Ernst A. Eberhardt R. Krasnik M. Herth F.J. Efficacy of endobronchial ultrasound-guided transbronchial needle aspiration of hilar lymph nodes for diagnosing and staging cancer.J Thorac Oncol. 2009; 4: 947-950Abstract Full Text Full Text PDF PubMed Scopus (87) Google Scholar]. EBUS-TBNA is also able to detect and collect samples from lymph nodes smaller than 1 cm [9Whitson B.A. Groth S.S. Maddaus M.A. Surgical assessment and intraoperative management of mediastinal lymph nodes in non-small cell lung cancer.Ann Thorac Surg. 2007; 84: 1059-1065Abstract Full Text Full Text PDF PubMed Scopus (74) Google Scholar]. However, EBUS-TBNA is an expensive technique and has a longer learning curve for bronchoscopists. Owing to a higher reported rate of false-negative results for EBUS-TBNA, EBUS-TBNA is followed by mediastinoscopy in patients with a negative result on EBUS-TBNA as a confirmative diagnosis when lung cancer is strongly suspected. Some studies have also reported contamination of samples with the fine needle used in EBUS-TBNA [10Vincent B.D. El-Bayoumi E. Hoffman B. Doelken P. DeRosimo J. Reed C. et al.Real-time endobronchial ultrasound-guided transbronchial lymph node aspiration.Ann Thorac Surg. 2008; 85: 224-230Abstract Full Text Full Text PDF PubMed Scopus (130) Google Scholar]. Many studies in the past decade have evaluated EBUS-TBNA as a minimally invasive technique for the staging of NSCLC. The number of patients analyzed within each study was small, however, leading to a wide precision on the derived estimates. A meta-analysis [11Gu P. Zhao Y.Z. Jiang L.Y. Zhang W. Xin Y. Han B.H. Endobronchial ultrasound-guided transbronchial needle aspiration for staging of lung cancer: a systematic review and meta-analysis.Eur J Cancer. 2009; 45: 1389-1396Abstract Full Text Full Text PDF PubMed Scopus (490) Google Scholar] that assessed the overall diagnostic value of EBUS-TBNA in detecting metastatic mediastinal lymph node also included studies in which EUS-FNA was used as a combined approach. The present meta-analysis was performed to ascertain pooled sensitivity and specificity of EBUS-TBNA in studies during the last 10 years that solely used EBUS-TBNA as a minimally invasive technique, with or without computed tomography (CT) or positron-emission tomography (PET) screening. A bibliographic search of medical literature from January 1995 to July 2012 was performed using PubMed, EMBASE, and Web of Science using the search string “endobronchial ultrasound” or “endobronchial ultrasonography” or “EBUS” or “endobronchial ultrasound-guided” and “TBNA” or “transbronchial needle aspiration” and “lung cancer” or “NSCLC” or “Lymphatic metastasis” or “Lung Neoplasm”. The Cochrane Library (www.cochranelibrary.com) was also searched. Reference lists of included studies and review articles were manually searched. Only original reports in English published in journals with a peer review process were included after reading the abstracts. The meta-analysis was limited to studies conducted in humans. Studies evaluating the sensitivity, specificity, accuracy, negative predictive value, and positive predictive values of EBUS-TBNA for the staging and diagnosis of lung cancer were included in the present meta-analysis. A clinical trial (randomized and nonrandomized) or retrospective, prospective, or cohort study was considered eligible for inclusion in the present meta-analysis if (1) EBUS-TBNA was used in pretreatment patients with suspected or previously diagnosed lung cancer for staging of mediastinal lymph nodes and (2) for per-patient statistics, sufficient data were presented to calculate the true-positive, false-negative, false-positive, and true-negative values. Exclusion criteria were (1) a study that evaluated EUS FNA or transbronchial lung biopsy (TBLB) simultaneously with EBUS-TBNA so that separate data could not be extracted for EBUS-TBNA, (2) a study of restaging after induction therapy, (3) outcome of interest was not reported, (4) the study contained previously published data, (5) the study included the diagnosis or staging of extrathoracic nodes/peripheral pulmonary lesions, (6) relevant data could not be extracted from the study, (7) studies with fewer than 10 patients, and (8) studies with previously published data. When multiple articles were published from a single institution, those with overlapping study periods were excluded. If multiple publications with overlapping study periods were observed, only one publication was included to prevent double counting of the patient cohorts. Abstracts of the articles matching the search criteria were retrieved and screened carefully by 2 independent authors to identify relevant articles. The full text of the potential articles that could be included in the present meta-analysis was reviewed carefully. The study quality was judged according to the technique used for the diagnosis of lung cancer, study type, and diagnostic yields. The reference lists of all the selected articles were crosschecked to identify relevant articles that had been missed in the primary search for inclusion. Articles extracted from the reference list of the selected articles were reviewed carefully before being considered for inclusion. Two independent authors assessed the quality of the articles included. The quality of the study was judged on the basis of study design (prospective, retrospective, or unknown), selection criteria of patients (pretreatment analysis with CT or PET scan, or bronchoscopy), and study population. The relevant data required for the extrapolation of results were extracted. These data included complete demographic information, and outcomes included diagnostic yield, accuracy, sensitivity, specificity, positive and negative predictive values with EBUS-TBNA, and the mean time required for the entire procedure. Publication bias was assessed with funnel plots, which demonstrate the relationship between the sample size of the studies and the precision in estimating the outcome. Bias can be seen if the plots are widely skewed compared with a plot resembling an inverted triangle, which represents no bias. Sensitivity, specificity, NPV, and PPV were calculated using actual numbers of true-positive, false-positive, true-negative, and false-negative results from the individual studies. A random effect model was used for the meta-analysis to obtain a summary estimate for sensitivity and specificity with 95% confidence intervals. A random effects meta-analysis model involves an assumption that the effects being estimated in the different studies are not identical but follow some distribution. The study heterogeneity was assessed, and a p value of less than 0.1 was considered to be suggestive of statistical heterogeneity. The statistical analysis was performed using SPSS software (SPSS Inc, Chicago, IL). The computerized search identified 168 studies; of these, 107 were excluded on the basis of title or abstract. The full text of 61 articles was retrieved and read by 2 independent authors. Finally, nine studies were included in the meta-analysis (Fig 1) [10Vincent B.D. El-Bayoumi E. Hoffman B. Doelken P. DeRosimo J. Reed C. et al.Real-time endobronchial ultrasound-guided transbronchial lymph node aspiration.Ann Thorac Surg. 2008; 85: 224-230Abstract Full Text Full Text PDF PubMed Scopus (130) Google Scholar, 12Herth F.J. Ernst A. Eberhardt R. Vilmann P. Dienemann H. Krasnik M. Endobronchial ultrasound-guided transbronchial needle aspiration of lymph nodes in the radiologically normal mediastinum.Eur Respir J. 2006; 28: 910-914Crossref PubMed Scopus (283) Google Scholar, 13Herth F.J. Eberhardt R. Krasnik M. Ernst A. Endobronchial ultrasound-guided transbronchial needle aspiration of lymph nodes in the radiologically and positron emission tomography-normal mediastinum in patients with lung cancer.Chest. 2008; 133: 887-891Abstract Full Text Full Text PDF PubMed Scopus (303) Google Scholar, 14Jhun B.W. Park H.Y. Jeon K. et al.Nodal stations and diagnostic performances of endobronchial ultrasound-guided transbronchial needle aspiration in patients with non-small cell lung cancer.J Korean Med Sci. 2012; 27: 46-51Crossref PubMed Scopus (25) Google Scholar, 15Lee H.S. Lee G.K. Lee H.S. et al.Real-time endobronchial ultrasound-guided transbronchial needle aspiration in mediastinal staging of non-small cell lung cancer: how many aspirations per target lymph node station?.Chest. 2008; 134: 368-374Abstract Full Text Full Text PDF PubMed Scopus (270) Google Scholar, 16Yasufuku K. Chiyo M. Sekine Y. Chhajed P.N. Shibuya K. Iizasa T. et al.Real-time endobronchial ultrasound-guided transbronchial needle aspiration of mediastinal and hilar lymph nodes.Chest. 2004; 126: 122-128Abstract Full Text Full Text PDF PubMed Scopus (580) Google Scholar, 17Yasufuku K. Nakajima T. Motoori K. et al.Comparison of endobronchial ultrasound, positron emission tomography, and CT for lymph node staging of lung cancer.Chest. 2006; 130: 710-718Abstract Full Text Full Text PDF PubMed Scopus (430) Google Scholar, 18Yasufuku K. Pierre A. Darling G. et al.A prospective controlled trial of endobronchial ultrasound-guided transbronchial needle aspiration compared with mediastinoscopy for mediastinal lymph node staging of lung cancer.J Thorac Cardiovasc Surg. 2011; 142 (e1): 1393-1400Abstract Full Text Full Text PDF PubMed Scopus (405) Google Scholar, 19Ye T. Hu H. Luo X. Chen H. The role of endobronchial ultrasound guided transbronchial needle aspiration (EBUS-TBNA) for qualitative diagnosis of mediastinal and hilar lymphadenopathy: a prospective analysis.BMC Cancer. 2011; 11: 100Crossref PubMed Scopus (50) Google Scholar]. We included clinical trials, prospective, retrospective, and cohort studies in our meta-analysis. The study characteristics of the included studies are reported in Table 1. Patients were enrolled prospectively in seven [12Herth F.J. Ernst A. Eberhardt R. Vilmann P. Dienemann H. Krasnik M. Endobronchial ultrasound-guided transbronchial needle aspiration of lymph nodes in the radiologically normal mediastinum.Eur Respir J. 2006; 28: 910-914Crossref PubMed Scopus (283) Google Scholar, 13Herth F.J. Eberhardt R. Krasnik M. Ernst A. Endobronchial ultrasound-guided transbronchial needle aspiration of lymph nodes in the radiologically and positron emission tomography-normal mediastinum in patients with lung cancer.Chest. 2008; 133: 887-891Abstract Full Text Full Text PDF PubMed Scopus (303) Google Scholar, 15Lee H.S. Lee G.K. Lee H.S. et al.Real-time endobronchial ultrasound-guided transbronchial needle aspiration in mediastinal staging of non-small cell lung cancer: how many aspirations per target lymph node station?.Chest. 2008; 134: 368-374Abstract Full Text Full Text PDF PubMed Scopus (270) Google Scholar, 16Yasufuku K. Chiyo M. Sekine Y. Chhajed P.N. Shibuya K. Iizasa T. et al.Real-time endobronchial ultrasound-guided transbronchial needle aspiration of mediastinal and hilar lymph nodes.Chest. 2004; 126: 122-128Abstract Full Text Full Text PDF PubMed Scopus (580) Google Scholar, 17Yasufuku K. Nakajima T. Motoori K. et al.Comparison of endobronchial ultrasound, positron emission tomography, and CT for lymph node staging of lung cancer.Chest. 2006; 130: 710-718Abstract Full Text Full Text PDF PubMed Scopus (430) Google Scholar, 18Yasufuku K. Pierre A. Darling G. et al.A prospective controlled trial of endobronchial ultrasound-guided transbronchial needle aspiration compared with mediastinoscopy for mediastinal lymph node staging of lung cancer.J Thorac Cardiovasc Surg. 2011; 142 (e1): 1393-1400Abstract Full Text Full Text PDF PubMed Scopus (405) Google Scholar, 19Ye T. Hu H. Luo X. Chen H. The role of endobronchial ultrasound guided transbronchial needle aspiration (EBUS-TBNA) for qualitative diagnosis of mediastinal and hilar lymphadenopathy: a prospective analysis.BMC Cancer. 2011; 11: 100Crossref PubMed Scopus (50) Google Scholar] of the nine studies, and two studies [10Vincent B.D. El-Bayoumi E. Hoffman B. Doelken P. DeRosimo J. Reed C. et al.Real-time endobronchial ultrasound-guided transbronchial lymph node aspiration.Ann Thorac Surg. 2008; 85: 224-230Abstract Full Text Full Text PDF PubMed Scopus (130) Google Scholar, 14Jhun B.W. Park H.Y. Jeon K. et al.Nodal stations and diagnostic performances of endobronchial ultrasound-guided transbronchial needle aspiration in patients with non-small cell lung cancer.J Korean Med Sci. 2012; 27: 46-51Crossref PubMed Scopus (25) Google Scholar] were retrospective. Three studies enrolled patients in a consecutive manner [10Vincent B.D. El-Bayoumi E. Hoffman B. Doelken P. DeRosimo J. Reed C. et al.Real-time endobronchial ultrasound-guided transbronchial lymph node aspiration.Ann Thorac Surg. 2008; 85: 224-230Abstract Full Text Full Text PDF PubMed Scopus (130) Google Scholar, 12Herth F.J. Ernst A. Eberhardt R. Vilmann P. Dienemann H. Krasnik M. Endobronchial ultrasound-guided transbronchial needle aspiration of lymph nodes in the radiologically normal mediastinum.Eur Respir J. 2006; 28: 910-914Crossref PubMed Scopus (283) Google Scholar, 13Herth F.J. Eberhardt R. Krasnik M. Ernst A. Endobronchial ultrasound-guided transbronchial needle aspiration of lymph nodes in the radiologically and positron emission tomography-normal mediastinum in patients with lung cancer.Chest. 2008; 133: 887-891Abstract Full Text Full Text PDF PubMed Scopus (303) Google Scholar]. The meta-analysis included 1,066 patients who underwent EBUS-TBNA. The patients were a mean age of 62.3 years, and most were men (mean number of women, 36). The patients underwent EBUS-TBNA on the basis of CT/PET results, and confirmation of EBUS-TBNA results was performed with thoracotomy, thoracoscopy, or mediastinoscopy. Histologic analysis of lung cancer in most patients showed adenocarcinoma (n = 46), followed by squamous cell carcinoma (n = 36). Four studies reported the mean time to perform EBUS-TBNA, and the pooled mean time of these studies was 23.8 minutes [14Jhun B.W. Park H.Y. Jeon K. et al.Nodal stations and diagnostic performances of endobronchial ultrasound-guided transbronchial needle aspiration in patients with non-small cell lung cancer.J Korean Med Sci. 2012; 27: 46-51Crossref PubMed Scopus (25) Google Scholar, 15Lee H.S. Lee G.K. Lee H.S. et al.Real-time endobronchial ultrasound-guided transbronchial needle aspiration in mediastinal staging of non-small cell lung cancer: how many aspirations per target lymph node station?.Chest. 2008; 134: 368-374Abstract Full Text Full Text PDF PubMed Scopus (270) Google Scholar, 17Yasufuku K. Nakajima T. Motoori K. et al.Comparison of endobronchial ultrasound, positron emission tomography, and CT for lymph node staging of lung cancer.Chest. 2006; 130: 710-718Abstract Full Text Full Text PDF PubMed Scopus (430) Google Scholar, 18Yasufuku K. Pierre A. Darling G. et al.A prospective controlled trial of endobronchial ultrasound-guided transbronchial needle aspiration compared with mediastinoscopy for mediastinal lymph node staging of lung cancer.J Thorac Cardiovasc Surg. 2011; 142 (e1): 1393-1400Abstract Full Text Full Text PDF PubMed Scopus (405) Google Scholar].Table 1Characteristics of the Studies Included in the Present Meta-AnalysisaAll of the studies had patients selected on the basis of positive results on computed tomography or positron emission tomography.First AuthorYearPatients (No.)Average Age (y)Study DesignPatient EnrollmentConfirmation of EBUS-TBNA– Positive ResultsStations Examined by EBUS-TBNASensitivity (%)Specificity (%)Yasufuku 16Yasufuku K. Chiyo M. Sekine Y. Chhajed P.N. Shibuya K. Iizasa T. et al.Real-time endobronchial ultrasound-guided transbronchial needle aspiration of mediastinal and hilar lymph nodes.Chest. 2004; 126: 122-128Abstract Full Text Full Text PDF PubMed Scopus (580) Google Scholar200410865.3ProspectiveNDOpen thoracotomy, thoracoscopy, or clinical follow-up2, 3, 4, 794.6100Yasufuku 17Yasufuku K. Nakajima T. Motoori K. et al.Comparison of endobronchial ultrasound, positron emission tomography, and CT for lymph node staging of lung cancer.Chest. 2006; 130: 710-718Abstract Full Text Full Text PDF PubMed Scopus (430) Google Scholar200610267.8ProspectiveNDThoracotomy with complete mediastinal lymph node dissection1, 2, 4, 5, 792.3100Yasufuku 18Yasufuku K. Pierre A. Darling G. et al.A prospective controlled trial of endobronchial ultrasound-guided transbronchial needle aspiration compared with mediastinoscopy for mediastinal lymph node staging of lung cancer.J Thorac Cardiovasc Surg. 2011; 142 (e1): 1393-1400Abstract Full Text Full Text PDF PubMed Scopus (405) Google Scholar201115366.8ProspectiveNDMediastinoscopy2, 4, 781100Lee 15Lee H.S. Lee G.K. Lee H.S. et al.Real-time endobronchial ultrasound-guided transbronchial needle aspiration in mediastinal staging of non-small cell lung cancer: how many aspirations per target lymph node station?.Chest. 2008; 134: 368-374Abstract Full Text Full Text PDF PubMed Scopus (270) Google Scholar200810264.3ProspectiveND…2, 4, 769.8100Jhun 12Herth F.J. Ernst A. Eberhardt R. Vilmann P. Dienemann H. Krasnik M. Endobronchial ultrasound-guided transbronchial needle aspiration of lymph nodes in the radiologically normal mediastinum.Eur Respir J. 2006; 28: 910-914Crossref PubMed Scopus (283) Google Scholar201215165RetrospectiveNDOperation1, 2, 3, 4, 791.998.4Ye 19Ye T. Hu H. Luo X. Chen H. The role of endobronchial ultrasound guided transbronchial needle aspiration (EBUS-TBNA) for qualitative diagnosis of mediastinal and hilar lymphadenopathy: a prospective analysis.BMC Cancer. 2011; 11: 100Crossref PubMed Scopus (50) Google Scholar201110157.4ProspectiveNDCytology, surgical results, and/or clinical follow-up2, 4, 7, 895.08100Herth 13Herth F.J. Eberhardt R. Krasnik M. Ernst A. Endobronchial ultrasound-guided transbronchial needle aspiration of lymph nodes in the radiologically and positron emission tomography-normal mediastinum in patients with lung cancer.Chest. 2008; 133: 887-891Abstract Full Text Full Text PDF PubMed Scopus (303) Google Scholar200610058.9ProspectiveConsecutiveMediastinoscopy or thoracotomy2, 4, 792.3100Herth 14Jhun B.W. Park H.Y. Jeon K. et al.Nodal stations and diagnostic performances of endobronchial ultrasound-guided transbronchial needle aspiration in patients with non-small cell lung cancer.J Korean Med Sci. 2012; 27: 46-51Crossref PubMed Scopus (25) Google Scholar20089752.9ProspectiveConsecutiveMediastinoscopy or thoracotomy4, 789100Vincent 10Vincent B.D. El-Bayoumi E. Hoffman B. Doelken P. DeRosimo J. Reed C. et al.Real-time endobronchial ultrasound-guided transbronchial lymph node aspiration.Ann Thorac Surg. 2008; 85: 224-230Abstract Full Text Full Text PDF PubMed Scopus (130) Google Scholar200815259.9RetrospectiveConsecutiveMediastinoscopy or lung resection2, 3, 4, 799.1100EBUS-TBNA = endobronchial ultrasound-guided transbronchial needle aspiration; ND = not defined.a All of the studies had patients selected on the basis of positive results on computed tomography or positron emission tomography. Open table in a new tab EBUS-TBNA = endobronchial ultrasound-guided transbronchial needle aspiration; ND = not defined. The funnel plot of sensitivity for the nine included studies (Fig 2) shows symmetry that indicates absence of publication bias. Figure 3 shows the forest plot of sensitivity of EBUS-TBNA. EBUS-TBNA had a pooled sensitivity of 0.90 (95% confidence interval, 0.84 to 0.96). The sensitivity in individual studies ranged from 0.69 [15Lee H.S. Lee G.K. Lee H.S. et al.Real-time endobronchial ultrasound-guided transbronchial needle aspiration in mediastinal staging of non-small cell lung cancer: how many aspirations per target lymph node station?.Chest. 2008; 134: 368-374Abstract Full Text Full Text PDF PubMed Scopus (270) Google Scholar] to 0.99 [10Vincent B.D. El-Bayoumi E. Hoffman B. Doelken P. DeRosimo J. Reed C. et al.Real-time endobronchial ultrasound-guided transbronchial lymph node aspiration.Ann Thorac Surg. 2008; 85: 224-230Abstract Full Text Full Text PDF PubMed Scopus (130) Google Scholar]. The study with lowest sensitivity [15Lee H.S. Lee G.K. Lee H.S. et al.Real-time endobronchial ultrasound-guided transbronchial needle aspiration in mediastinal staging of non-small cell lung cancer: how many aspirations per target lymph node station?.Chest. 2008; 134: 368-374Abstract Full Text Full Text PDF PubMed Scopus (270) Google Scholar] was a retrospective analysis of 152 consecutive EBUS-TBNA procedures in patients with a primary lung mass or undiagnosed mediastinal adenopathy. Rapid on-site cytopathologic evaluation (ROSE) was used for all procedures. The random effects model for sensitivity of included studies showed the presence of heterogeneity (I2 = 87.2%), indicating that most of the variability across studies was due to heterogeneity rather than chance.Fig 3Forest plot shows sensitivity of endobronchial ultrasound-guided transbronchial needle aspiration. (CI = confidence interval.)View Large Image Figure ViewerDownload Hi-res image Download (PPT) The pooled specificity of the studies was 0.99. All studies but one had specificity of 100% [14Jhun B.W. Park H.Y. Jeon K. et al.Nodal stations and diagnostic performances of endobronchial ultrasound-guided transbronchial needle aspiration in patients with non-small cell lung cancer.J Korean Med Sci. 2012; 27: 46-51Crossref PubMed Scopus (25) Google Scholar]. This study reported a false-positive result in 1 patient, and specificity of EBUS-TBNA in this study was 98.4%. The pooled accuracy of the included studies was 0.96. The pooled PPV was 0.99 and pooled NPV was 0.93. Eight studies presented data for complications with EBUS-TBNA. Hypoxemia was only reported in one study [15Lee H.S. Lee G.K. Lee H.S. et al.Real-time endobronchial ultrasound-guided transbronchial needle aspiration in mediastinal staging of non-small cell lung cancer: how many aspirations per target lymph node station?.Chest. 2008; 134: 368-374Abstract Full Text Full Text PDF PubMed Scopus (270) Google Scholar], which occurred in one patient after two aspirations from the 4R station. This patient also had chronic obstructive pulmonary disorder before the procedure. The present meta-analysis was conducted to evaluate EBUS-TBNA as a tool in the staging of NSCLC. We conducted this meta-analysis and included prospective and retrospective studies (between December 2005 and January 2012) to evaluate the sensitivity, specificity, NPV, PPV, and accuracy of EBUS-TBNA in the diagnosis of mediastinal lymph nodes. The meta-analysis focused only on those studies that included the evaluation of the mediastinum using EBUS-TBNA. Few of the studies included in the present meta-analysis used ROSE [14Jhun B.W. Park H.Y. Jeon K. et al.Nodal stations and diagnostic performances of endobronchial ultrasound-guided transbronchial needle aspiration in patients with non-small cell lung cancer.J Korean Med Sci. 2012; 27: 46-51Crossref PubMed Scopus (25) Google Scholar, 15Lee H.S. Lee G.K. Lee H.S. et al.Real-time endobronchial ultrasound-guided transbronchial needle aspiration in mediastinal staging of non-small cell lung cancer: how many aspirations per target lymph node station?.Chest. 2008; 134: 368-374Abstract Full Text Full Text PDF PubMed Scopus (270) Google Scholar, 18Yasufuku K. Pierre A. Darling G. et al.A prospective controlled trial of endobronchial ultrasound-guided transbronchial needle aspiration compared with mediastinoscopy for mediastinal lymph node staging of lung cancer.J Thorac Cardiovasc Surg. 2011; 142 (e1): 1393-1400Abstract Full Text Full Text PDF PubMed Scopus (405) Google Scholar], a cost-effective technique that improves the diagnostic accuracy to a significant extent. Inclusion of ROSE to the analysis with EBUS-TBNA also reduces the total time of the procedure in addition to its benefits related to cost-effectiveness and diagnostic accuracy [15Lee H.S. Lee G.K. Lee H.S. et al.Real-time endobronchial ultrasound-guided transbronchial needle aspiration in mediastinal staging of non-small cell lung cancer: how many aspirations per target lymph node station?.Chest. 2008; 134: 368-374Abstract Full Text Full Text PDF PubMed Scopus (270) Google Scholar]. The funnel plot for sensitivity showed symmetry, and the presence of publication bias was eliminated. The pooled sensitivity, specificity, PPV, and NPV of EBUS-TBNA in 1,066 patients were 0.90, 0.99, 0.99, and 0.93, respectively. Only 1 patient of the total 1,066 patients showed a false-positive result with EBUS-TBNA. We observed heterogeneity in the random effects model between the studies in our meta-analysis (I2 = 87.2%). The between-studies variability is due to the influence of an indeterminate number of characteristics that vary among the studies, such as characteristics of the samples, variations in the technique used, and the design quality. The variability in the present meta-analysis might be because of patient selection on the basis of CT or PET results, because studies in this meta-analysis included patients screened by CT/PET techniques. Although the use of CT and PET scan is common in primary screening, these cannot establish the presence of malignancy and require examination with mediastinoscopy for confirmed results. Though considered better than CT (sensitivity, 60%; specificity, 81%), PET is also not sensitive (84%) or specific (89%) enough to determine mediastinal node involvement [20Rintoul R.C. Skwarski K.M. Murchison J.T. Wallace W.A. Walker W.S. Penman I.D. Endobronchial and endoscopic ultrasound-guided real-time fine-needle aspiration for mediastinal staging.Eur Respir J. 2005; 25: 416-421Crossref PubMed Scopus (265) Google Scholar]. In all but one study in the present meta-analysis patients were screened with CT/PET before undergoing EBUS-TBNA [20Rintoul R.C. Skwarski K.M. Murchison J.T. Wallace W.A. Walker W.S. Penman I.D. Endobronchial and endoscopic ultrasound-guided real-time fine-needle aspiration for mediastinal staging.Eur Respir J. 2005; 25: 416-421Crossref PubMed Scopus (265) Google Scholar]. In one of the included studies, the mediastinum was normal on CT/PET [13Herth F.J. Eberhardt R. Krasnik M. Ernst A. Endobronchial ultrasound-guided transbronchial needle aspiration of lymph nodes in the radiologically and positron emission tomography-normal mediastinum in patients with lung cancer.Chest. 2008; 133: 887-891Abstract Full Text Full Text PDF PubMed Scopus (303) Google Scholar], but despite negative CT and PET scan results, EBUS-TBNA of mediastinal lymph nodes was positive for metastatic disease in 8 patients. This study reported only 1 patient as having a false-negative result with EBUS-TBNA. One of the included studies compared EBUS-TBNA, CT and PET for lymph node staging [17Yasufuku K. Nakajima T. Motoori K. et al.Comparison of endobronchial ultrasound, positron emission tomography, and CT for lymph node staging of lung cancer.Chest. 2006; 130: 710-718Abstract Full Text Full Text PDF PubMed Scopus (430) Google Scholar]. This study reported considerably lower sensitivity and specificity of CT (sensitivity, 76.9%; specificity, 55.3%) and PET (sensitivity, 80%; specificity, 70.1%) compared with EBUS-TBNA (sensitivity, 92.3%; specificity, 100%). Mediastinoscopy, considered the gold standard for staging the mediastinum, is an invasive procedure, has a sensitivity of 80% to 90%, and the rate of false-negative diagnosis is 10% to 15% [20Rintoul R.C. Skwarski K.M. Murchison J.T. Wallace W.A. Walker W.S. Penman I.D. Endobronchial and endoscopic ultrasound-guided real-time fine-needle aspiration for mediastinal staging.Eur Respir J. 2005; 25: 416-421Crossref PubMed Scopus (265) Google Scholar]. Compared with mediastinoscopy, EBUS-TBNA offers the advantage of being able to reach posterior mediastinal and hilar lymph nodes, under moderate sedation, that cannot be reached by mediastinoscopy [12Herth F.J. Ernst A. Eberhardt R. Vilmann P. Dienemann H. Krasnik M. Endobronchial ultrasound-guided transbronchial needle aspiration of lymph nodes in the radiologically normal mediastinum.Eur Respir J. 2006; 28: 910-914Crossref PubMed Scopus (283) Google Scholar, 21Chung F.T. Kuo C.H. Chen H.C. et al.Roles of EBUS-TBNA in non-small cell lung cancer.Thoracic Cancer. 2012; 3: 182-187Crossref PubMed Scopus (4) Google Scholar, 22Medford A.R. Endobronchial ultrasound-guided transbronchial needle aspiration: onwards and upwards.Thoracic Cancer. 2011; 2: 131-133Crossref PubMed Scopus (1) Google Scholar]. EBUS-TBNA can be performed easily in the outpatient unit with considerably lower rates of morbidity compared with other techniques [13Herth F.J. Eberhardt R. Krasnik M. Ernst A. Endobronchial ultrasound-guided transbronchial needle aspiration of lymph nodes in the radiologically and positron emission tomography-normal mediastinum in patients with lung cancer.Chest. 2008; 133: 887-891Abstract Full Text Full Text PDF PubMed Scopus (303) Google Scholar]. In addition, EBUS-TBNA can be used to perform the diagnosis and staging of NSCLC simultaneously among patients with suspected lung cancer. In most of the included studies in the present meta-analysis, mediastinoscopy was used to confirm results of EBUS-TBNA. Only one included study compared EBUS-TBNA and mediastinoscopy for mediastinal lymph node staging of lung cancer and concluded that EBUS-TBNA could replace mediastinoscopy because of the excellent agreement between the two techniques (91% κ = 0.8) [18Yasufuku K. Pierre A. Darling G. et al.A prospective controlled trial of endobronchial ultrasound-guided transbronchial needle aspiration compared with mediastinoscopy for mediastinal lymph node staging of lung cancer.J Thorac Cardiovasc Surg. 2011; 142 (e1): 1393-1400Abstract Full Text Full Text PDF PubMed Scopus (405) Google Scholar]. We did not include studies with a combined approach but focused on studies that used only EBUS-TBNA as the sole minimally invasive technique or where separate data for EBUS-TBNA could be extracted. A previous meta-analysis by Gu and colleagues [11Gu P. Zhao Y.Z. Jiang L.Y. Zhang W. Xin Y. Han B.H. Endobronchial ultrasound-guided transbronchial needle aspiration for staging of lung cancer: a systematic review and meta-analysis.Eur J Cancer. 2009; 45: 1389-1396Abstract Full Text Full Text PDF PubMed Scopus (490) Google Scholar] assessed the overall diagnostic value of EBUS-TBNA but also included studies that used combined approach of EBUS-TBNA and EUS-FNA in detecting metastatic mediastinal lymph nodes. This meta-analysis concluded that combined EBUS-TBNA and EUS-FNA could achieve nearly complete minimally invasive mediastinal staging. EBUS-TBNA is an extremely safe technique for the diagnosis of NSCLC. The nodal stations affect the diagnostic yield of EBUS-TBNA due to the anatomic structure. Lymph nodes with short-axis and long-axis diameters can both be easily identified with EBUS-TBNA for the presence of metastatic involvement [14Jhun B.W. Park H.Y. Jeon K. et al.Nodal stations and diagnostic performances of endobronchial ultrasound-guided transbronchial needle aspiration in patients with non-small cell lung cancer.J Korean Med Sci. 2012; 27: 46-51Crossref PubMed Scopus (25) Google Scholar]. Our review of the complications observed for EBUS-TBNA for the present meta-analysis of 1,066 patients found a complication in 1 patient with a history of chronic obstructive pulmonary disease. This patient experienced hypoxemia when exposed to EBUS-TBNA for a second aspiration from the lung [15Lee H.S. Lee G.K. Lee H.S. et al.Real-time endobronchial ultrasound-guided transbronchial needle aspiration in mediastinal staging of non-small cell lung cancer: how many aspirations per target lymph node station?.Chest. 2008; 134: 368-374Abstract Full Text Full Text PDF PubMed Scopus (270) Google Scholar]. The results of the present study show an excellent performance of EBUS-TBNA in the diagnosis of mediastinal lymph nodes in patients with NSCLC. However, the meta-analysis has certain limitations. Firstly, the studies on usage of EBUS-TBNA come from only some institutes, and therefore, the excellent results are generated from only a handful of experts. Thus, it is difficult to generalize the results to bronchoscopists with less experience. The learning curve for those who have just started out using this technique might be long. Secondly, most of the studies did not mention the number of aspirations; however, one study [15Lee H.S. Lee G.K. Lee H.S. et al.Real-time endobronchial ultrasound-guided transbronchial needle aspiration in mediastinal staging of non-small cell lung cancer: how many aspirations per target lymph node station?.Chest. 2008; 134: 368-374Abstract Full Text Full Text PDF PubMed Scopus (270) Google Scholar] showed that sensitivity of EBUS-TBNA increased considerably, from 69.8% in first aspiration to 95.3% in the fourth aspiration, suggesting that one needle pass per nodal station is insufficient for staging of NSCLC. Lastly, reference tests used in the included studies varied and had suboptimal descriptions. This limited our ability to comment on their accuracy and make a comparison. In conclusion, the present meta-analysis demonstrated that EBUS-TBNA is a potential technique for the investigation, diagnosis, and staging of NSCLC among patients with suspected lung cancer. EBUS-TBNA is well tolerated and does not lead to complications in patients. It has shown excellent sensitivity, specificity, PPV, and NPV values. However; more organized and larger studies, especially randomized controlled trials, are required to confirm additional benefits of EBUS-TBNA.